Efficacy and Adherence of Xalacom Combination Therapy in Glaucoma Patients Switching from a Multi-Drug Therapy (PG and beta blocker medication)

Phase 4

• Conditions: Glaucoma, ocular hypertension

• Registration Number: JPRN-UMIN000007042
• Lead Sponsor: Department of Ophthalmology, Kitasato University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-10
• Study Completion: 2012-06-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients in whom the studied drug is "Contraindication" 2) Patients in whom the studied drug is "Careful Administration" 3) Patients with corneal abnormalities that would hinder the measurement of IOP using Goldmann applanation tonometry 4) Patients whose pupils could dilate so insufficiently that it is impossible to observe optic papillae 5) Patients with a history of a laser treatment 6) Patients with uveititis, an eye injury, an infectious eye disease or an inflammatory eye disease as an accompanying disease 7) Patients with a history of narrow angle that may be closed, or acute angle closure 8) Patients with a retinal disease that might affect the visual field of either or both eyes, as an accompanying disease 9) Patients with a history of an infectious disease within four weeks of participation in this study 10) Patients who had been using any drug that might have a systemic effect that affects intraocular pressure 11) Patients assessed as unsuitable for participation in the study by the investigator and/or subinvestigators

Study & Design

• Study Type: Interventional
• Study Design: Not specified